North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 12, 2026

January 12, 2026

Nurses Ranked Most Trusted Profession for 24th Consecutive Year

GlobeNewswire

January 12, 2026

Kraig Biocraft Laboratories Takes Possession of Third Rearing Center, Completing Core Infrastructure Upgrades for 2026 Production Scale-Up

GlobeNewswire

January 12, 2026

Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors

GlobeNewswire

January 12, 2026

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

January 12, 2026

BillionToOne Provides Guidance for 2026

GlobeNewswire

January 12, 2026

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

GlobeNewswire

January 12, 2026

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

GlobeNewswire

January 12, 2026

Wellcome Leap and Medicines360 Announce Partnership to Accelerate Development and Access to New Lifesaving Pregnancy and Stillbirth Risk-Reduction Tools for Women Worldwide

GlobeNewswire

January 12, 2026

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

GlobeNewswire

January 12, 2026

Gradalis Appoints Steven D. Weinstein as Chief Executive Officer

GlobeNewswire

January 12, 2026

Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Milestone Payment Under Collaboration with Sanofi

GlobeNewswire

January 12, 2026

Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2

GlobeNewswire

January 12, 2026

NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection

GlobeNewswire

January 12, 2026

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

GlobeNewswire

January 12, 2026

Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones

GlobeNewswire

January 12, 2026

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

GlobeNewswire

January 12, 2026

Cabaletta Bio Announces 2026 Strategic Priorities

GlobeNewswire

January 12, 2026

Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones

GlobeNewswire

January 12, 2026

IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma

GlobeNewswire

January 12, 2026

Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio

GlobeNewswire